Liver disease in cystic fibrosis.

The influence of genetics on cystic fibrosis phenotypes. Cold Spring Harb Perspect Med (2012) 1.07

An update on laboratory diagnosis of liver inherited diseases. Biomed Res Int (2013) 0.80

Bone disease in cystic fibrosis: new pathogenic insights opening novel therapies. Osteoporos Int (2015) 0.79

Genetic modifiers of liver disease in cystic fibrosis. JAMA (2009) 1.88

Clinical presentation of and outcome for solitary rectal ulcer syndrome in children. J Pediatr Gastroenterol Nutr (2012) 1.84

Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol (2010) 1.60

Cystic fibrosis-associated liver disease: a population-based study. J Pediatr (2004) 1.55

Age-specific incidence of Helicobacter pylori. Gastroenterology (2006) 1.45

A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol (2005) 1.41

Importance of parental conceptual model of illness in severe recurrent abdominal pain. Pediatrics (2003) 1.24

Enteric campylobacter: purging its secrets? Pediatr Res (2003) 1.16

Campylobacter jejuni adhere to and invade chicken intestinal epithelial cells in vitro. Microbiology (2007) 1.14

Probiotic colonization of the adherent mucus layer of HT29MTXE12 cells attenuates Campylobacter jejuni virulence properties. Infect Immun (2010) 1.12

Identification of a mutation in LARS as a novel cause of infantile hepatopathy. Mol Genet Metab (2012) 1.08

Mucosal reactive oxygen species decrease virulence by disrupting Campylobacter jejuni phosphotyrosine signaling. Cell Host Microbe (2012) 1.08

Interaction of Cryptosporidium hominis and Cryptosporidium parvum with primary human and bovine intestinal cells. Infect Immun (2006) 1.06

The incidence of cyclic vomiting syndrome in children: population-based study. Am J Gastroenterol (2007) 0.97

Looking in the mouth for Crohn's disease. Inflamm Bowel Dis (2010) 0.95

Invasion of human epithelial cells by Campylobacter upsaliensis. Cell Microbiol (2003) 0.92

Host cell tropism underlies species restriction of human and bovine Cryptosporidium parvum genotypes. Infect Immun (2004) 0.91

Outcome in cystic fibrosis liver disease. Am J Gastroenterol (2010) 0.90

Purified chicken intestinal mucin attenuates Campylobacter jejuni pathogenicity in vitro. J Med Microbiol (2010) 0.89

Divergent mechanisms of interaction of Helicobacter pylori and Campylobacter jejuni with mucus and mucins. Infect Immun (2013) 0.86

Defense and adaptation: the complex inter-relationship between Campylobacter jejuni and mucus. Front Cell Infect Microbiol (2012) 0.85

Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia. Am J Hematol (2010) 0.85

How to use Helicobacter pylori testing in paediatric practice. Arch Dis Child Educ Pract Ed (2012) 0.83

Do the Rome criteria help the doctor or the patient? J Pediatr Gastroenterol Nutr (2005) 0.79

Random mutagenesis to identify novel Helicobacter mustelae virulence factors. FEMS Immunol Med Microbiol (2007) 0.78

Cj1411c encodes for a cytochrome P450 involved in Campylobacter jejuni 81-176 pathogenicity. PLoS One (2013) 0.77

Cryptogenic, multifocal, ulcerous, and stenosing enteritis as a manifestation of enterocolic venopathy. J Pediatr Gastroenterol Nutr (2008) 0.76

Behavioral and nutritional treatment to improve energy intake and growth in toddlers and preschool-aged children with cystic fibrosis. Pediatrics (2006) 0.75

Peutz-Jeghers syndrome and management recommendations. Clin Gastroenterol Hepatol (2006) 0.75